Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

December Approvals Forecast: FDA Decisions Will Be Fast And Frequent

This article was originally published in The Pink Sheet Daily

Executive Summary

Another record-breaking year of approvals seems almost certain given the number of products with user fee goals before the end of 2015.


Related Content

HCV Forecast: Merck, AbbVie Next-Gen Data Not Overtaking Gilead


Related Companies